Open Access

Clinical characteristics and prognosis of pediatric patients with B cell acute lymphoblastic leukemia relapse

  • Authors:
    • Xiaohong Zhang
    • Haixia Wu
    • Hong Fan
    • Baifang Su
    • Ge Zhang
    • Lin Dong
  • View Affiliations

  • Published online on: June 18, 2018     https://doi.org/10.3892/ol.2018.8974
  • Pages: 2929-2934
  • Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The aim of the present study was to investigate the clinical characteristics and prognosis of pediatric patients with B cell acute lymphoblastic leukemia (B-ALL) relapse. A total of 390 pediatric patients diagnosed as B-ALL and receiving regular chemotherapy in Jining First People's Hospital from August 2010 to May 2016 were selected. The clinical characteristics, therapeutic response and prognosis were compared between the two groups. There were significant differences in the comparisons of age, leukocyte count in the initial diagnosis and glucocorticoid sensitive test between B-cell ALL (B-ALL) relapse group and non-relapse group; the minimal residual disease (MRD) levels of pediatric patients in the two groups at 33 days and 12 weeks were significantly different. The 3-year event-free survival (EFS) rates of pediatric patients with early, medium and late B-ALL relapse were 12.5±7.8%, 33.1±9.8% and 63.6±6.1%, respectively, and the prognosis of late relapse was significantly better than that of early relapse (P<0.001). The 3-year EFS rates of pediatric patients with bone marrow relapse in standard risk group, intermediate risk group and high risk group were 29.1±6.9, 31.3±6.5 and 28.3±6.3%, respectively; there were no statistically significant differences (P=0.387, P>0.05). Pediatric patients with B-ALL relapse are characterized by higher onset age (≥10 years old), high leukocyte count and hormone insensitivity. Dynamic monitoring of MRD level in B-ALL pediatric patients can predict the relapse.
View Figures
View References

Related Articles

Journal Cover

September-2018
Volume 16 Issue 3

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhang X, Wu H, Fan H, Su B, Zhang G and Dong L: Clinical characteristics and prognosis of pediatric patients with B cell acute lymphoblastic leukemia relapse. Oncol Lett 16: 2929-2934, 2018.
APA
Zhang, X., Wu, H., Fan, H., Su, B., Zhang, G., & Dong, L. (2018). Clinical characteristics and prognosis of pediatric patients with B cell acute lymphoblastic leukemia relapse. Oncology Letters, 16, 2929-2934. https://doi.org/10.3892/ol.2018.8974
MLA
Zhang, X., Wu, H., Fan, H., Su, B., Zhang, G., Dong, L."Clinical characteristics and prognosis of pediatric patients with B cell acute lymphoblastic leukemia relapse". Oncology Letters 16.3 (2018): 2929-2934.
Chicago
Zhang, X., Wu, H., Fan, H., Su, B., Zhang, G., Dong, L."Clinical characteristics and prognosis of pediatric patients with B cell acute lymphoblastic leukemia relapse". Oncology Letters 16, no. 3 (2018): 2929-2934. https://doi.org/10.3892/ol.2018.8974